Strong Upregulation of AIM2 and IFI16 Inflammasomes in the Mucosa of Patients with Active Inflammatory Bowel Disease-Reference-Cited by-同舟云学术

Strong Upregulation of AIM2 and IFI16 Inflammasomes in the Mucosa of Patients with Active Inflammatory Bowel Disease

Published:2015-11 Issue:11 Volume:21 Page:2673-2682
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:Inflammatory Bowel Diseases

Author:

Vanhove Wiebe,Peeters Paul M.,Staelens Dominiek,Schraenen Anica,Van der Goten Jan,Cleynen Isabelle,De Schepper Sebastiaan,Van Lommel Leentje,Reynaert Niki L.,Schuit Frans,Van Assche Gert,Ferrante Marc,De Hertogh Gert,Wouters Emiel F. M.,Rutgeerts Paul,Vermeire Séverine,Nys Kris,Arijs Ingrid

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

Reference50 articles.

1. Biological Therapies for Inflammatory Bowel Diseases

2. Genetics and pathogenesis of inflammatory bowel disease

3. Intestinal barrier dysfunction in inflammatory bowel diseases

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Key Disease-Related Genes and Immune Cell Infiltration Landscape in Inflammatory Bowel Disease: A Bioinformatics Investigation;International Journal of Molecular Sciences;2024-09-09

2. IFI-16 inhibition attenuates myocardial remodeling following myocardial infarction;iScience;2024-08

3. Identification of shared disease marker genes and underlying mechanisms between rheumatoid arthritis and Crohn disease through bioinformatics analysis;Medicine;2024-06-28

4. Chromatin as alarmins in necrotizing enterocolitis;Frontiers in Immunology;2024-05-31

5. The role of IFI16 in regulating PANoptosis and implication in heart diseases;Cell Death Discovery;2024-05-01